S
Simone Lista
Researcher at University of Paris
Publications - 126
Citations - 7378
Simone Lista is an academic researcher from University of Paris. The author has contributed to research in topics: Dementia & Disease. The author has an hindex of 39, co-authored 116 publications receiving 5166 citations. Previous affiliations of Simone Lista include French Institute of Health and Medical Research & ICM Partners.
Papers
More filters
Journal ArticleDOI
Preclinical Alzheimer's disease: Definition, natural history, and diagnostic criteria.
Bruno Dubois,Harald Hampel,Harald Hampel,Howard Feldman,Philip Scheltens,Paul S. Aisen,Sandrine Andrieu,Hovagim Bakardjian,Habib Benali,Lars Bertram,Lars Bertram,Kaj Blennow,Karl Broich,Enrica Cavedo,Sebastian J. Crutch,Jean-François Dartigues,Charles Duyckaerts,Stéphane Epelbaum,Giovanni B. Frisoni,Serge Gauthier,Remy Genthon,Alida A. Gouw,Alida A. Gouw,Marie-Odile Habert,David M. Holtzman,Miia Kivipelto,Miia Kivipelto,Simone Lista,José Luis Molinuevo,Sid E. O'Bryant,Gil D. Rabinovici,Christopher C. Rowe,Stephen Salloway,Lon S. Schneider,Reisa A. Sperling,Reisa A. Sperling,Marc Teichmann,Maria C. Carrillo,Jeffrey L. Cummings,Cliff R. Jack +39 more
TL;DR: An updated review of the literature and evidence on the definitions and lexicon, the limits, the natural history, the markers of progression, and the ethical consequence of detecting the disease at this asymptomatic stage of Alzheimer's disease are provided.
Journal ArticleDOI
Blood-based biomarkers for Alzheimer disease: mapping the road to the clinic.
Harald Hampel,Sid E. O'Bryant,José Luis Molinuevo,Henrik Zetterberg,Colin L. Masters,Simone Lista,Steven J. Kiddle,Steven J. Kiddle,Richard Batrla,Kaj Blennow,Kaj Blennow +10 more
TL;DR: This Review summarizes the efforts of an international working group that aimed to survey the current landscape of blood-based AD biomarkers and outlines operational steps for an effective academic–industry co-development pathway from identification and assay development to validation for clinical use.
Journal ArticleDOI
The β-Secretase BACE1 in Alzheimer's Disease.
Harald Hampel,Robert Vassar,Bart De Strooper,Bart De Strooper,Bart De Strooper,John Hardy,Michael Willem,Neeraj Kumar Singh,John Zhou,Riqiang Yan,Eugeen Vanmechelen,Ann De Vos,Robert Nisticò,Massimo Corbo,Bruno P. Imbimbo,Johannes Streffer,Iryna Voytyuk,Iryna Voytyuk,Iryna Voytyuk,Maarten Timmers,Maarten Timmers,Amir Abbas Tahami Monfared,Amir Abbas Tahami Monfared,Michael C. Irizarry,Bruce Albala,Akihiko Koyama,Naoto Watanabe,Teiji Kimura,Lisa Yarenis,Simone Lista,Simone Lista,Lynn D. Kramer,Andrea Vergallo +32 more
TL;DR: BACE1 concentrations and rates of activity are increased in AD brains and body fluids, thereby supporting the hypothesis that BACE1 plays a critical role in AD pathophysiology, and is a prime drug target for slowing down Aβ production in early AD.
Journal ArticleDOI
Cerebrospinal fluid and blood biomarkers for neurodegenerative dementias: An update of the Consensus of the Task Force on Biological Markers in Psychiatry of the World Federation of Societies of Biological Psychiatry
Piotr Lewczuk,Peter Riederer,Sid E. O'Bryant,Marcel M. Verbeek,Bruno Dubois,Pieter Jelle Visser,Kurt A. Jellinger,Sebastiaan Engelborghs,Alfredo Ramirez,Lucilla Parnetti,Clifford R. Jack,Charlotte E. Teunissen,Harald Hampel,Alberto Lleó,Frank Jessen,Lidia Glodzik,Mony J. de Leon,Anne M. Fagan,José Luis Molinuevo,Willemijn J. Jansen,Bengt Winblad,Leslie M. Shaw,Ulf Andreasson,Markus Otto,Brit Mollenhauer,Jens Wiltfang,Martin R Turner,Inga Zerr,Ron Handels,Alexander G. Thompson,Gunilla Johansson,Natalia Ermann,John Q. Trojanowski,Ilker Karaca,Holger Wagner,Patrick Oeckl,Linda J C van Waalwijk van Doorn,Maria Bjerke,Dimitrios Kapogiannis,H. Bea Kuiperij,Lucia Farotti,Yi Li,Brian A. Gordon,Stéphane Epelbaum,Stephanie J.B. Vos,Catharina J.M. Klijn,William E. Van Nostrand,Carolina Minguillon,Matthias Schmitz,Carla Gallo,Andrea Lopez Mato,Florence Thibaut,Simone Lista,Daniel Alcolea,Henrik Zetterberg,Kaj Blennow,Johannes Kornhuber +56 more
TL;DR: In the 12 years since the publication of the first Consensus Paper of the WFSBP on biomarkers of neurodegenerative dementias, enormous advancement has taken place in the field, and the Task Force takes the opportunity to extend and update the original paper.
Journal ArticleDOI
Subjective cognitive decline and rates of incident Alzheimer's disease and non–Alzheimer's disease dementia
Rosalinde E.R. Slot,Sietske A.M. Sikkes,Johannes Berkhof,Henry Brodaty,Rachel F. Buckley,Rachel F. Buckley,Enrica Cavedo,Efthimios Dardiotis,Francoise Guillo-Benarous,Harald Hampel,Nicole A. Kochan,Simone Lista,Tobias Luck,Paul Maruff,José Luis Molinuevo,Johannes Kornhuber,Barry Reisberg,Steffi G. Riedel-Heller,Shannon L. Risacher,Susanne Roehr,Perminder S. Sachdev,Nikolaos Scarmeas,Nikolaos Scarmeas,Philip Scheltens,Melanie B. Shulman,Andrew J. Saykin,Sander C.J. Verfaillie,Pieter Jelle Visser,Pieter Jelle Visser,Stephanie J.B. Vos,Michael Wagner,Michael Wagner,Steffen Wolfsgruber,Steffen Wolfsgruber,Frank Jessen,Frank Jessen,Mercè Boada,Peter Paul De Deyn,Roy W. Jones,Giovanni B. Frisoni,L. Spiru,Flavio Nobili,Yvonne Freund-Levi,Hilkka Soininen,Frans R.J. Verhey,Åsa K. Wallin,Jacques Touchon,Marcel G. M. Olde Rikkert,Anne-Sophie Rigaud,Roger Bullock,Magda Tsolaki,Bruno Vellas,Gordon K. Wilcock,Lutz Froelich,Hovagim Bakardjian,Habib Benali,Hugo Bertin,Joel Bonheur,Laurie Boukadida,Nadia Boukerrou,Patrizia A. Chiesa,Olivier Colliot,Bruno Dubois,Marion Dubois,Stéphane Epelbaum,Geoffroy Gagliardi,Remy Genthon,M.-O. Habert,Marion Houot,Aurélie Kas,Foudil Lamari,Marcel Levy,Christiane Metzinger,Fanny Mochel,Francis Nyasse,Catherine Poisson,Marie-Claude Potier,Marie Revillon,Antonio Carlos dos Santos,Katia Andrade,Marine Sole,Mohmed Surtee,Michel Thiebaud de Schotten,Andrea Vergallo,Nadjia Younsi,Wiesje M. van der Flier +85 more
TL;DR: The incidence of Alzheimer's disease and non‐AD dementia and determinants of progression to dementia are assessed and subjective cognitive decline in community‐based and memory clinic settings is assessed.